Effects of Topical Treatment of Foot Rot in Sheep Using Ozonated Olive Ointment.
antioxidant/oxidant balance
foot rot
ozonated olive ointment
sheep
Journal
Journal of veterinary research
ISSN: 2450-7393
Titre abrégé: J Vet Res
Pays: Poland
ID NLM: 101696630
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
24
03
2021
accepted:
27
08
2021
entrez:
17
12
2021
pubmed:
18
12
2021
medline:
18
12
2021
Statut:
epublish
Résumé
Foot rot in small ruminants is highly contagious, causes severe lameness, and impairs fertility and wool and meat production. It is usually treated with parenteral antibiotics, with attendant antibiotic resistance risk, and with bactericidal footbaths, potentially harmful to humans and the environment. An alternative treatment in sheep is proposed based on repeated topical ozonated ointment application. Its effectiveness and safety were evaluated by estimation of acute-phase response, biochemical indicators of organic damage, and antioxidant/oxidant balance (AOB). The study was conducted on ten sheep with Egerton scale 2-3 lesions. Ozone application was repeated every day for seven days. Blood was drawn first (T0) after foot cleaning and before ozonation, then (T1) seven days after the first ozone application, and finally (T2) four days after the last application. High clinical effectiveness was observed, with total recovery by 28 days from the start of treatment. A significant increase in antiradical activity was noted on the basis of a 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) assay from 1.16 ± 0.04 μmolTe/mL at T0 to 1.23 ± 0.03 μmolTe/mL at T1, with a slight decrease in oxidative stress. Calculated on the basis of antiradical capacity, AOB was higher at T1 (130 ± 19%) and decreased to 110 ± 16% at T2. Calculated on the basis of reducing power, it was 169 ± 22% at T1 and 131 ± 17% at T2. These results indicated that the AOB is efficient enough to prevent oxidative organ injury and the applied doses of ozone are safe for animals.
Identifiants
pubmed: 34917851
doi: 10.2478/jvetres-2021-0050
pii: jvetres-2021-0050
pmc: PMC8643082
doi:
Types de publication
Journal Article
Langues
eng
Pagination
369-374Informations de copyright
© 2021 T. Szponder et al. published by Sciendo.
Déclaration de conflit d'intérêts
Conflict of Interest Conflict of Interests Statement: The authors declare that there is no conflict of interests regarding the publication of this article.
Références
Eur J Pharmacol. 2012 Sep 15;691(1-3):156-62
pubmed: 22796450
Anim Reprod Sci. 2015 Aug;159:1-7
pubmed: 26059777
Molecules. 2018 Mar 13;23(3):
pubmed: 29534008
Free Radic Biol Med. 1999 May;26(9-10):1231-7
pubmed: 10381194
Expert Opin Biol Ther. 2017 Jun;17(6):663-676
pubmed: 28368216
J Pediatr Surg. 2009 Sep;44(9):1730-5
pubmed: 19735816
Molecules. 2018 Dec 07;23(12):
pubmed: 30544620
Food Chem. 2017 Apr 15;221:278-288
pubmed: 27979203
Braz J Otorhinolaryngol. 2017 Mar - Apr;83(2):168-175
pubmed: 27174776
J Clin Microbiol. 2018 Mar 26;56(4):
pubmed: 29436426
BMC Vet Res. 2012 Jan 31;8:12
pubmed: 22293088
Toxicol Mech Methods. 2010 Jan;20(1):25-30
pubmed: 20017603
Molecules. 2018 Mar 30;23(4):
pubmed: 29601469
Antioxidants (Basel). 2019 Nov 26;8(12):
pubmed: 31779159